TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Ebba Biotech AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,372
|
1,243
|
994 |
| Financial expenses |
10
|
13
|
11 |
| Earnings before taxes |
-1,355
|
-1,212
|
-2,271 |
| EBITDA |
-1,302
|
-1,158
|
-2,223 |
| Total assets |
868
|
822
|
1,201 |
| Current assets |
815
|
723
|
1,081 |
| Current liabilities |
236
|
296
|
541 |
| Equity capital |
129
|
190
|
392 |
| - share capital |
41
|
42
|
42 |
| Employees (average) |
4
|
4
|
4 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
14.9%
|
23.1%
|
32.6% |
| Turnover per employee |
343
|
311
|
248 |
| Profit as a percentage of turnover |
-98.8%
|
-97.5%
|
-228.5% |
| Return on assets (ROA) |
-155.0%
|
-145.9%
|
-188.2% |
| Current ratio |
345.3%
|
244.3%
|
199.8% |
| Return on equity (ROE) |
-1050.4%
|
-637.9%
|
-579.3% |
| Change turnover |
170
|
244
|
217 |
| Change turnover % |
14%
|
24%
|
28% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0%
|
33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.